AR008171A1 - IRON REGULATED PROMOTER, A RECOMBINANT DNA MOLECULA, A RECOMBINANT VECTOR, A RECOMBINANT ANPHITRION CELL, A COMPOSITION FOR USE IN THE INDUCTION OF AN IMMUNE RESPONSE IN AN ANIMAL, A RECOMBINANT CELL AND A METOD AND A METOD - Google Patents
IRON REGULATED PROMOTER, A RECOMBINANT DNA MOLECULA, A RECOMBINANT VECTOR, A RECOMBINANT ANPHITRION CELL, A COMPOSITION FOR USE IN THE INDUCTION OF AN IMMUNE RESPONSE IN AN ANIMAL, A RECOMBINANT CELL AND A METOD AND A METODInfo
- Publication number
- AR008171A1 AR008171A1 ARP970104095A ARP970104095A AR008171A1 AR 008171 A1 AR008171 A1 AR 008171A1 AR P970104095 A ARP970104095 A AR P970104095A AR P970104095 A ARP970104095 A AR P970104095A AR 008171 A1 AR008171 A1 AR 008171A1
- Authority
- AR
- Argentina
- Prior art keywords
- recombinant
- metod
- cell
- animal
- immune response
- Prior art date
Links
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 title abstract 4
- 108020004511 Recombinant DNA Proteins 0.000 title abstract 2
- 230000028993 immune response Effects 0.000 title abstract 2
- 229910052742 iron Inorganic materials 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000001105 regulatory effect Effects 0.000 title abstract 2
- 239000013598 vector Substances 0.000 title abstract 2
- 230000006698 induction Effects 0.000 title 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 102000053602 DNA Human genes 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
- C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Se provee un promotor regulado por hierro. El promotor comprende la secuencia de ADN mostrada en la Fig.1 o un fragmento de la misma la cualincluye la secuencia de los residuos 284 a 409, o una secuencia de ácido nucleico funcionalmente equivalente. También se proveen vectores y célulasanfitriones recombinantes que incluyen el promotor y las composiciones para uso de inducción de una respuesta inmune en un animal. Se proveen además unamolécula de ADN recombinante y un método paraproducir una célula huésped recombinante.An iron-regulated promoter is provided. The promoter comprises the DNA sequence shown in Fig. 1 or a fragment thereof which includes the sequence of residues 284 to 409, or a functionally equivalent nucleic acid sequence. Recombinant host cells and vectors including the promoter and compositions are also provided for use in inducing an immune response in an animal. A recombinant DNA molecule and a method for producing a recombinant host cell are further provided.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPO2164A AUPO216496A0 (en) | 1996-09-06 | 1996-09-06 | Inducible promoters |
| AUPO2454A AUPO245496A0 (en) | 1996-09-19 | 1996-09-19 | Site-specific chromosomal integration system |
| AUPO7801A AUPO780197A0 (en) | 1997-07-09 | 1997-07-09 | Site-specific chromosomal integration system incorporating inducible promoter |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR008171A1 true AR008171A1 (en) | 1999-12-09 |
Family
ID=27157946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970104095A AR008171A1 (en) | 1996-09-06 | 1997-09-08 | IRON REGULATED PROMOTER, A RECOMBINANT DNA MOLECULA, A RECOMBINANT VECTOR, A RECOMBINANT ANPHITRION CELL, A COMPOSITION FOR USE IN THE INDUCTION OF AN IMMUNE RESPONSE IN AN ANIMAL, A RECOMBINANT CELL AND A METOD AND A METOD |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0964924A4 (en) |
| AR (1) | AR008171A1 (en) |
| BR (1) | BR9711692A (en) |
| CA (1) | CA2265883A1 (en) |
| NZ (1) | NZ334649A (en) |
| UY (1) | UY24698A1 (en) |
| WO (1) | WO1998010064A1 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0563311B1 (en) * | 1990-12-18 | 2000-03-15 | The General Hospital Corporation | Improved vaccines |
| CA2156191A1 (en) * | 1993-02-22 | 1994-09-01 | Stephen B. Calderwood | Heterologous antigens in live cell vaccine strains |
-
1997
- 1997-08-08 WO PCT/AU1997/000503 patent/WO1998010064A1/en not_active Application Discontinuation
- 1997-08-08 EP EP97933590A patent/EP0964924A4/en not_active Withdrawn
- 1997-08-08 CA CA002265883A patent/CA2265883A1/en not_active Abandoned
- 1997-08-08 BR BR9711692-0A patent/BR9711692A/en unknown
- 1997-08-08 NZ NZ334649A patent/NZ334649A/en unknown
- 1997-09-05 UY UY24698A patent/UY24698A1/en not_active Application Discontinuation
- 1997-09-08 AR ARP970104095A patent/AR008171A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ334649A (en) | 2000-08-25 |
| BR9711692A (en) | 2000-10-24 |
| EP0964924A4 (en) | 2001-04-18 |
| WO1998010064A1 (en) | 1998-03-12 |
| CA2265883A1 (en) | 1998-03-12 |
| UY24698A1 (en) | 1998-02-12 |
| EP0964924A1 (en) | 1999-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69435292D1 (en) | METHOD FOR THE PRODUCTION OF IMMUNOGENOUS HLA-A2.1-BINDING PEPTIDES | |
| AR018346A1 (en) | PROMOTING MUTANT PEPTIDES OF CELLULAR IMMUNITY T, PHARMACEUTICAL COMPOSITIONS AND VACCINES FORMULATED WITH SUCH PEPTIDES FOR DECANCER TREATMENT; USE OF SUCH PEPTIDES, METHOD FOR IDENTIFYING SUCH PEPTIDES AND DNA SEQUENCES THAT CODIFY SUCH MUTANT AND VECTORS AND PLASMID PEPTIDES | |
| ATE270337T1 (en) | MATERIALS AND METHODS RELATED TO BINDING AND PRESENTATION OF SUBSTANCES ON CELL SURFACES | |
| DE69324359D1 (en) | IMPROVED METHOD FOR PRODUCING ENDOTOXIN BINDING PROTEINS | |
| ATE250133T1 (en) | CTOR-MEDIATED GENOME INSERTION AND EXPRESSION OF DNA IN BCG | |
| NL980006I1 (en) | Antigenic preparations and isolation of such preparations. | |
| MX9203519A (en) | RECOMBINATION METHOD FOR THE PRODUCTION OF SERINE PROTEASE INHIBITORS AND DNA SEQUENCES USEFUL FOR THEM. | |
| DE69515340T2 (en) | VACCINE AGAINST MYCOBACTERIAL INFECTIONS | |
| ES2085928T3 (en) | GEN AND PROTEIN SEQUENCE OF THE HUMAN MK. | |
| DE69018926D1 (en) | Vaccine against Bordetella. | |
| NO862690D0 (en) | MONOCLONAL ANTIBODIES AND ANTIGENS FOR HUMAN NON-SMALL-CELL LUNGCARCINOMES (NSCLC). | |
| FI940036A0 (en) | Nucleotide sequences and cycloheximide resistant proteins | |
| ATE356831T1 (en) | NEW GALANIN RECEPTOR | |
| AR008171A1 (en) | IRON REGULATED PROMOTER, A RECOMBINANT DNA MOLECULA, A RECOMBINANT VECTOR, A RECOMBINANT ANPHITRION CELL, A COMPOSITION FOR USE IN THE INDUCTION OF AN IMMUNE RESPONSE IN AN ANIMAL, A RECOMBINANT CELL AND A METOD AND A METOD | |
| NZ333265A (en) | Vaccine containing peroxiredoxin and/or beta-tubulin of fluke origin to immunise against parasitic infestation of helminths in mammals | |
| ES554327A0 (en) | A PROCEDURE FOR PREPARING A RECOMBINANT PLASMID | |
| ATE174963T1 (en) | CLONING AND EXPRESSION OF A RHOPTRY-ASSOCIATED PROTEIN FROM P. FALCIPARUM | |
| DK43991A (en) | GENERAL PLASTS OF PLASMODIUM FALCIPARUM MEROZOIT SURFACE ANTIGEN | |
| SE9604439D0 (en) | New receptor | |
| IT1177378B (en) | PSM112 PLASMIDIC VECTOR FOR EXPRESSION IN BACILLUS SUBTILIS | |
| CA2025938A1 (en) | Cloning of the gene which codes for the pilinic subunit fim3 of bordetella pertussis | |
| DE69128095D1 (en) | CELLULAR VACCINE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |